XHP is committed to providing timely access to biomedical research. JCTH(IF: 4.2) | ERHM | JERP | JCTP | CSP | FIM | GE | JTG | Oncology Advances | NSSS

Texas, USA
Joined June 2016
📊 US cholangitis mortality rose from 0.25 to 0.46 per 100,000 adults aged 25+ from 1999 to 2023. A national analysis highlights persistent disparities. @BASLedu #Cholangitis #HealthEquity 🔗 xiahepublishing.com/2472-071…
12
🔬 Solvents can influence measured drug-target binding. An editorial calls for testing co-solvent effects and interpreting affinity data with care. @BritPharmSoc #Pharmacology #DrugDiscovery 🔗 xiahepublishing.com/2572-550…
23
🧠 Arterial spin labeling measures brain perfusion without injected contrast. A letter explores neurosurgical applications and the hurdles to routine use. @ISMRM #ArterialSpinLabeling #Neurosurgery 🔗 xiahepublishing.com/3067-615…
31
🔬 Could redox remodeling expose cancer vulnerabilities? A commentary on Arnicolide C connects oxidative signaling to MYC suppression in preclinical models. @CR_UK #CancerResearch #NaturalProducts 🔗 xiahepublishing.com/2835-635…
21
💡 Cancer vaccines, RNA therapeutics and engineered T-cell signaling featured at a 2025 Cuba symposium. A letter reflects on emerging immunotherapy directions. @sitcancer #CancerImmunotherapy #CancerVaccines 🔗 xiahepublishing.com/1555-388…
37
💡 Could blocking LDL desialylation curb atherogenesis? An editorial examines sialidase inhibition as an experimental route to limit lipid-driven inflammation. @escardio #Atherosclerosis #LipidBiology 🔗 xiahepublishing.com/1555-388…
32